Belviso LUMINA PDRN

A new category of subtle rejuvenation: Soft Enhancement

Belviso LUMINA PDRN has been presented as a new-generation skin booster with a gel-like, ultra-light consistency, designed for a therapy described as Soft Enhancement. This denotes an intermediate approach between classic mesotherapy, biostimulation and gentle tissue filling. The product is intended to combine a soft-filler effect, 3D hydration and gentle remodeling — i.e. delicate support, intensive spatial hydration and a mild improvement in skin quality.

Its formula is based on a combination of lightly cross-linked Shiseido hyaluronic acid, PDRN, biomimetic peptides and a PBS buffer. The aim of such a composition is not heavy volumisation or radical facial modelling, but a subtle improvement of the profile, smoothing of superficial folds, skin regeneration and reinforcement of tissue quality without an overloading effect.

Which patient is the product intended for

Belviso LUMINA PDRN has been designed for people expecting a natural, soft and harmonious effect. According to the presentation, it is a product for patients who require subtle elevation of structures, smoothing without the “heaviness” typical of classic fillers, improvement of the facial profile, regeneration of tissues and ligaments, and results without the risk of over-accentuation.

In practice, this means it is particularly useful in patients with thin, tired, dehydrated or lax skin, in whom a classic filler might give an effect that is too heavy or unnatural. The product fits into the philosophy of regenerative aesthetics: rather than changing facial features, it aims to improve tissue quality, resilience, density, hydration and optical freshness.

Lightly cross-linked hyaluronic acid: soft filler, hydration and elastic support

The first key ingredient of the product is lightly cross-linked hyaluronic acid. Its role has been defined in the presentation as Soft Filler + Hydration + Elastic Support. Thanks to its light gel consistency, HA forms a three-dimensional, low-viscosity network that enables gentle smoothing of superficial folds and subtle volume restoration.

Unlike classic, denser fillers, this component is intended not to burden the tissues and to allow precise application also in thinner areas. The presentation also emphasises a high level of stability, even distribution of the molecules and no tendency to excessive swelling. The clinical effect is intended to be the smoothing of fine mimic wrinkles, increased tissue elasticity, support for epidermal regeneration and preparation of the skin for deeper stimulation.

PDRN: DNA regeneration, tissue repair and ligament support

The second pillar of Belviso LUMINA PDRN is PDRN, i.e. Sodium Polyribonucleotide. The presentation attributes to it a regenerative, anti-inflammatory and tissue-repairing role. PDRN is intended to activate A2A receptors, support fibroblasts in producing type I and III collagen, and improve tissue perfusion and metabolism.

A particularly interesting element of the presentation is the concept of the Ligament Booster. The product is intended to support the regeneration of the supporting structures of the face, such as the zygomatic, cheek and mandibular ligaments. From a clinical standpoint this is important, because the ageing process involves not only the skin but also the weakening of the supporting structures, loss of firmness and deterioration in the stability of the soft tissues.

In this framework, Belviso LUMINA PDRN does not act like a classic volumising product. Its task is rather to improve the quality and resilience of the tissues around the points of support, which may reinforce the effect of other lifting procedures and delay the deepening of laxity.

Acetyl Hexapeptide-8: a botox-like effect without freezing facial expression

The third active ingredient indicated in the presentation is Acetyl Hexapeptide-8, a peptide described as “botox-like.” Its role is to reduce muscle tension and smooth wrinkles arising from facial expression. According to the material, this peptide inhibits the release of catecholamines and acetylcholine, reduces the intensity of facial expression and gently smooths marionette lines, crow’s feet and transverse wrinkles.

What is most important here is the character of the action: it is not about pharmacological paralysis of the muscle, as in the case of botulinum toxin, but about a gentler relaxing effect. The product may therefore be of interest to patients who fear botulinum toxin, wish to preserve natural facial expression or expect smoothing without a “frozen” effect.

Palmitoyl Pentapeptide-4: a reparative and anti-ageing peptide

The fourth important component is Palmitoyl Pentapeptide-4, described as a reparative and anti-ageing peptide. Its task is to activate fibroblasts towards more intensive collagen synthesis, increase skin thickness and improve its resistance to laxity.

The presentation describes its action with the metaphor of “skin within skin,” i.e. the reconstruction of an internal scaffold. In practice, this means structural support for the dermis, improved density and gradual strengthening of the tissues. In combination with PDRN and hyaluronic acid, this peptide complements the product’s action with a component of long-term remodelling.

PBS: stability, biocompatibility and safe pH

The formula is completed by Phosphate-Buffered Saline, i.e. the PBS buffer. Its task is to maintain a stable environment for the active ingredients, ensure an appropriate pH, minimise the risk of irritation and support even distribution of the product within the tissues.

This element is technologically important, because multi-component products require a stable carrier that makes it possible to preserve the properties of the active substances and limit unpredictable local reactions.

Mechanism of action: soft filler plus biostimulator

Belviso LUMINA PDRN has been described as a hybrid combining gentle filling and biostimulation. The “soft-filler” effect results primarily from the light, gel-like hyaluronic acid, which improves hydration, smooths superficial folds and provides subtle support. The regenerative effect results from PDRN and biomimetic peptides, which support fibroblasts, collagenogenesis, microcirculation and tissue remodelling.

Such a combination makes it possible to achieve the effect of rested, firmer and more radiant skin without the impression that the patient “has just had a procedure.” This is an important difference compared with the classic volumising approach, where the primary aim is to add volume. In the case of Belviso LUMINA PDRN, the aim is rather to improve the biological and biomechanical quality of the skin.

Significance for the facial profile and the ligaments

On page 8 of the presentation, particular emphasis was placed on action in the area of the facial ligaments, described as True Lifting Points. The product is intended to improve tissue density around the ligaments, strengthen their support, stabilise the structure of the cheek, jawline and temples, and prolong the effect of lifting performed with other products.

The indications in this respect are tissue sagging at the jawline, loss of volume in the temples and loss of support in the area of the marionette lines and nasolabial folds. This is not, however, a product intended for aggressive contouring. Its role is to strengthen and improve the quality of the supporting structures, not to “sculpt” the face.

Areas of application

Thanks to its light, gel-like consistency, Belviso LUMINA PDRN can be used in many areas of the face and body. Within the face, the presentation indicates the nasolabial folds as an area of gentle soft-filling, the marionette lines, the temple area, the cheek areas, the lip area and the smoker’s lines.

On the neck, the product can be used for transverse “neck creases,” laxity and poor skin density. On the hands, its use includes revitalisation, filling of fine skin folds and improvement of skin hydration and thickness. On the décolletage, the aim of the therapy is to reduce fine folds and to even out and hydrate the skin.

Treatment schedule

According to the presentation, the recommended frequency is one procedure every 4–6 weeks. A treatment series usually consists of 3–4 procedures, while a booster procedure can be performed every 3–6 months.

This schedule corresponds to the product’s mechanism of action. Part of the effect, related to hydration and light support, may be visible sooner. The regenerative effect, resulting from fibroblast stimulation, collagen remodelling and improved tissue density, requires time and repeated stimulation.

Off-label applications

The presentation also indicates possible off-label applications intended for experienced professionals. These include the infraorbital area, fine lines in the forehead area, revitalisation of the skin around the mouth and the jawline as ligament reinforcement.

In these areas, particular caution is necessary. The infraorbital area requires very gentle application into the dermis and the avoidance of injection that is too deep or linear. The jawline should be treated as an area for strengthening support, rather than for classic modelling or contouring.

Off-label applications should in every case be preceded by medical qualification, risk assessment, the patient’s informed consent and documentation of the procedure.

Precautions

The presentation indicates that the product should not be used in areas of severe lymphatic oedema, in patients with active inflammation or infection, in areas with active nodules following PMMA, silicone or other permanent implants, and during pregnancy and lactation.

Particular caution is required in the infraorbital area, in patients with coagulation disorders and in people who have undergone strong laser treatment or deep peeling within the last 14 days. The material also emphasises avoiding injection that is too deep, since Belviso LUMINA PDRN is not a classic volumising filler.

The clinical significance of the product

Belviso LUMINA PDRN fits into the modern direction of aesthetic therapies, in which the priority is skin quality rather than volume alone. The product can be a valuable tool in patients who expect natural rejuvenation, improved skin luminosity, gentle support and regeneration without excessively burdening the tissues.

Its greatest value is the multidirectional nature of its action: hyaluronic acid is responsible for soft filling and hydration, PDRN supports regeneration and tissue repair, Acetyl Hexapeptide-8 reduces mimic tension, and Palmitoyl Pentapeptide-4 supports the reconstruction of the skin’s collagen scaffold.

Summary

Belviso LUMINA PDRN is a hybrid skin booster with a soft-filler effect, 3D hydration and gentle remodeling. Its formula combines lightly cross-linked Shiseido hyaluronic acid, PDRN, biomimetic peptides and a PBS buffer, creating a product oriented towards subtle support, regeneration, hydration and improvement of tissue quality.

This is not a classic product for heavy volumisation. Its place is in therapies for natural rejuvenation, improvement of the facial profile, revitalisation of the skin of the neck, décolletage and hands, and support of the ligamentary structures. The final effect is intended to be soft, elegant, harmonious and subtle.

This article is informational and educational in nature and does not replace the product’s instructions for use, registration documentation, procedural training, specialist qualification or the individual clinical decision.